Positive Review

A Canadian expert panel report recommends public coverage of the gene therapy Kymriah if its cost goes down, the Globe and Mail reports.

Kymriah, a CAR-T therapy from Novartis, has been approved by Health Canada to treat acute lymphoblastic leukemia in children and diffuse large B-cell lymphoma in adults, it notes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.